Article de revue
Use of tetanus-diphtheria (Td) vaccine in children 4–7 years of age: World Health Organization consultation of experts
Td (reduced diphtheria toxoid, ≥2–5 IU) vaccines are currently licensed for ages 7 years and older, but use of Td vaccine for ages 4 years and older would have advantages for immunization programs in many low- and middle-income countries. For this reason, WHO convened an expert consultation to review the currently available evidence for the use of Td vaccine from 4 to 7 years of age.
Langues
- Anglais
Année de publication
2020
Journal
Vaccine
Volume
21
Type
Article de revue
Catégories
- Gestion de programme
Maladies
- Diphtérie
- Tétanos
Organisations
- Organisation Mondiale de la Santé (OMS)
EPI-CORE-TETANUS
| Titre | Auteur | Année | Type | Langue |
|---|---|---|---|---|
| Validation of Maternal and Neonatal Tetanus Elimination | World Health Organization (WHO) | 2014 | Guidance | Anglais, Français |
| Use of tetanus-diphtheria (Td) vaccine in children 4–7 years of age: World Health Organization consultation of experts | Tracey Goodman, Thomas Cherian, Heather M. Scobie, S. Desai | 2020 | Journal article | Anglais |
| Replacement of TT with Td vaccine – July 2018 | UNICEF, World Health Organization (WHO) | 2018 | Guidance | Français |
| Protecting All Against Tetanus: Guide to sustaining maternal and neonatal tetanus elimination (MNTE) and broadening tetanus protection for all populations | World Health Organization (WHO) | 2019 | Guidance | Anglais |
